These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception. Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1. Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885 [TBL] [Abstract][Full Text] [Related]
7. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129 [TBL] [Abstract][Full Text] [Related]
8. Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women. Ghosh M; Daniels J; Pyra M; Juzumaite M; Jais M; Murphy K; Taylor TN; Kassaye S; Benning L; Cohen M; Weber K PLoS One; 2018; 13(6):e0198412. PubMed ID: 29894487 [TBL] [Abstract][Full Text] [Related]
9. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228 [TBL] [Abstract][Full Text] [Related]
10. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions. Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267 [TBL] [Abstract][Full Text] [Related]
11. Lifetime sexual violence exposure in women compromises systemic innate immune mediators associated with HIV pathogenesis: A cross-sectional analysis. Daniels J; Aldous A; Pyra M; Xia Y; Juzumaite M; Jais M; Simmens S; Murphy K; Taylor TN; Kassaye S; Benning L; Cohen MH; Weber KM; Ghosh M Womens Health (Lond); 2022; 18():17455057221099486. PubMed ID: 35579000 [TBL] [Abstract][Full Text] [Related]
12. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition. Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477 [TBL] [Abstract][Full Text] [Related]
13. Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls. Ghosh M; Jais M; Biswas R; Jarin J; Daniels J; Joy C; Juzumaite M; Emmanuel V; Gomez-Lobo V Am J Reprod Immunol; 2018 Jun; 79(6):e12846. PubMed ID: 29533494 [TBL] [Abstract][Full Text] [Related]
14. Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers. Yao XD; Omange RW; Henrick BM; Lester RT; Kimani J; Ball TB; Plummer FA; Rosenthal KL Mucosal Immunol; 2014 Mar; 7(2):268-79. PubMed ID: 23801306 [TBL] [Abstract][Full Text] [Related]
15. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding. Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777 [TBL] [Abstract][Full Text] [Related]
16. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. Hwang LY; Scott ME; Ma Y; Moscicki AB J Reprod Immunol; 2011 Jan; 88(1):66-71. PubMed ID: 21051089 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. McKinnon LR; Nyanga B; Chege D; Izulla P; Kimani M; Huibner S; Gelmon L; Block KE; Cicala C; Anzala AO; Arthos J; Kimani J; Kaul R J Immunol; 2011 Dec; 187(11):6032-42. PubMed ID: 22048765 [TBL] [Abstract][Full Text] [Related]
18. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status. Ghosh M; Jais M; Delisle J; Younes N; Benyeogor I; Biswas R; Mohamed H; Daniels J; Wang C; Young M; Kassaye S AIDS Res Hum Retroviruses; 2019 Mar; 35(3):251-259. PubMed ID: 30618272 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. Hirbod T; Nilsson J; Andersson S; Uberti-Foppa C; Ferrari D; Manghi M; Andersson J; Lopalco L; Broliden K J Acquir Immune Defic Syndr; 2006 Oct; 43(2):137-43. PubMed ID: 16940859 [TBL] [Abstract][Full Text] [Related]
20. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]